Celyad SA ADR Stock
Your prediction
Celyad SA ADR Stock
Our community identified positive and negative aspects for Celyad SA ADR stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Celyad SA ADR stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Celyad SA ADR in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
B****
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Celyad SA ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Celyad SA ADR | - | - | - | - | - | - | - |
| Cardio3 Biosciences S.A. | - | 0.382% | -2.593% | -68.541% | -2.593% | -89.563% | -97.995% |
| Chromadex Corp | -1.610% | -4.314% | -11.273% | -12.857% | -11.273% | 168.058% | 22.613% |
| Intellia Therapeutics Inc | -4.310% | -10.311% | 42.070% | 9.748% | 42.070% | -70.031% | -78.541% |